Autophagy Disruptions Associated With Altered Optineurin Expression in Extranigral Regions in a Rotenone Model of Parkinson's Disease

被引:9
作者
Wise, John P., Jr. [1 ,2 ]
Price, Charles G. [1 ]
Amaro, Joseph A. [1 ,3 ]
Cannon, Jason R. [1 ,2 ]
机构
[1] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA
[2] Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA
[3] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
来源
FRONTIERS IN NEUROSCIENCE | 2018年 / 12卷
基金
美国国家卫生研究院;
关键词
Parkinson's disease; rotenone; autophagy; optineurin; LC3; GENE-ENVIRONMENT INTERACTIONS; MITOCHONDRIAL-DNA DAMAGE; LEWY BODY DISEASES; ALPHA-SYNUCLEIN; DOPAMINERGIC-NEURONS; NIGRAL NEURONS; DIAGNOSTIC-CRITERIA; OXIDATIVE STRESS; PATHOLOGY; LOCALIZATION;
D O I
10.3389/fnins.2018.00289
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The motor features of Parkinson's disease (PD) primarily result from a lesion to the nigrostriatal dopamine system. Numerous non-motor symptoms occur in PD, many of which are postulated to stem from pathology outside of the nigrostriatal dopamine system. Perturbations to protein trafficking, disruption of mitochondrial integrity, and impaired autophagy have repeatedly been implicated in dopaminergic neuron cell death. Previously, we demonstrated that multiple markers of autophagy are disrupted in a rotenone model of PD, with alterations occurring prior to an overt lesion to the nigrostriatal dopamine system. Whether these events occur in extra-nigral nuclei in PD and when relative to a lesion in the nigrostriatal dopamine system are generally unknown. The primary goal of these studies was to determine whether autophagy disruptions, in non-dopaminergic neuronal populations occur in an environmental model of PD utilizing a mitochondria' toxin. Here, we utilized the rat rotenone PD model, with sampling time-points before and after an overt lesion to the nigrostriatal dopamine system. In analyzing autophagy changes, we focused on optineurin (OPTN) and the autophagy marker, LC3. OPTN is an autophagy cargo adapter protein genetically linked to amyotrophic lateral sclerosis and glaucoma. In the present study, we observed OPTN enrichment in all PD-relevant brain regions examined. Further, alterations in OPTN and LC3 expression and colocalized puncta suggest specific impairments to autophagy that will inform future mechanistic studies. Thus, our data suggest that autophagy disruptions may be critical to PD pathogenesis in non-dopaminergic neurons and the onset of non-motor symptoms.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Effects of ozone treatment to the levels of neurodegeneration biomarkers after rotenone induced rat model of Parkinson's disease
    Algin, Asuman Kaplan
    Tomruk, Canberk
    Aslan, Cigdem Gozde
    Akkurt, Sinan Saban
    Cinar, Gulcihan Mehtap
    Ulukaya, Sezgin
    Uyanikgil, Yigit
    Akcay, Yasemin
    NEUROSCIENCE LETTERS, 2023, 814
  • [42] Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinson's disease
    Fernandez, M.
    Barcia, E.
    Fernandez-Carballido, A.
    Garcia, L.
    Slowing, K.
    Negro, S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 438 (1-2) : 266 - 278
  • [43] Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson's Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation
    Sharma, Monika
    Malim, Fehmina Mushtaque
    Goswami, Ashutosh
    Sharma, Nishant
    Juvvalapalli, Sai Sowmya
    Chatterjee, Sayan
    Kate, Abhijeet S.
    Khairnar, Amit
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2023, 6 (01) : 40 - 51
  • [44] Neuroprotective effects of curcumin on the cerebellum in a rotenone-induced Parkinson's Disease Model
    Fikry, Heba
    Saleh, Lobna A.
    Gawad, Sara Abdel
    CNS NEUROSCIENCE & THERAPEUTICS, 2022, 28 (05) : 732 - 748
  • [45] Xanthotoxin modulates oxidative stress, inflammation, and MAPK signaling in a rotenone-induced Parkinson's disease model
    Sayed, Aya S.
    Sayed, Nesrine S. El
    Budzynska, Barbara
    Skalicka-Wozniak, Krystyna
    Ahmed, Mariam K.
    Kandil, Esraa A.
    LIFE SCIENCES, 2022, 310
  • [46] Time Course of Neurobehavioral Disruptions and Regional Brain Metabolism Changes in the Rotenone Mice Model of Parkinson's Disease
    Troshev, Dmitry
    Voronkov, Dmitry
    Pavlova, Anastasia
    Abaimov, Denis
    Latanov, Alexander
    Fedorova, Tatiana
    Berezhnoy, Daniil
    BIOMEDICINES, 2022, 10 (02)
  • [47] Neuroprotective effect of dexpanthenol on rotenone-induced Parkinson's disease model in rats
    Egilmez, Cansu Bilister
    Pazarlar, Burcu Azak
    Erdogan, Mumin Alper
    Erbas, Oytun
    NEUROSCIENCE LETTERS, 2024, 818
  • [48] Altered hippocampal doublecortin expression in Parkinson's disease
    Placido, Evelini
    Koss, David J.
    Outeiro, Tiago Fleming
    Brocardo, Patricia S.
    JOURNAL OF NEUROCHEMISTRY, 2024, 168 (08) : 1514 - 1526
  • [49] Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease
    Farombi, Ebenezer O.
    Awogbindin, Ifeoluwa O.
    Farombi, Temitope H.
    Oladele, Johnson O.
    Izomoh, Edirin R.
    Aladelokun, Oladimeji B.
    Ezekiel, Ibukunoluwa O.
    Adebambo, Oluwabunmi, I
    Abah, Victoria O.
    NEUROTOXICOLOGY, 2019, 73 : 132 - 141
  • [50] Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson's disease
    Moon, Soung Hee
    Kwon, Yoonjung
    Huh, Young Eun
    Choi, Hyun Jin
    ARCHIVES OF PHARMACAL RESEARCH, 2022, 45 (06) : 417 - 432